View drug registration information details.


ItemsRegistration information
ID413
No413
Brand NameALDACTONE
IngredientsSPIRONOLACTONE 25 MG
Dosage FormTABLET
Primary PackagingALU-STRIP
StorageSTORE BELOW 30'C
Shelf Life24 MONTH
Pack SizeBOX OF 10 X 10'S
Dispensing CategoryPrescription only
ATC ClassificationC03DA01
Pharmaceutical ClassDIURETICS
IndicationsESSENTIAL HYPERTENSION, SHORT-TERM PREOPERATIVE TREATMENT OF PATIENTS WITH PRIMARY HYPERALDOSTERONISM, DIURETIC-INDUCED HYPOKALEMIA/HYPOMAGNESEMIA AS ADJUNCTIVE THERAPY, MANAGEMENT OF HIRSUTISM.
ContraindicationsSPIRONOLACTONE IS CONTRAINDICATED IN PATIENTS WITH THE FOLLOWING : * ACUTE RENAL INSUFFICIENCY, SIGNIFICANT RENAL COMPROMISE
Side EffectsTHE FOLLOWING ADVERSE EVENTS HAVE BEEN REPORTED IN ASSOCIATION WITH SPIRONOLONE THERAPY : NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED ( INCL CYSTS AND POLYPS)
Unit Price-
EDL Yes
DescriptionBUFF COLOURED, BICONVEX TABLETS, ONE SIDE SCORED,OTHER SIDE STAMPED '' SEARLE'' PEPPERMINT ODOR.
Note
License OwnerDKSH LAOS COMPANY LIMITED
ManufacturerOLIC (THAILAND) LIMITED
CountryTHAILAND
Import Registration No1A 872/27
Import Registration Date1984-07-25
ActivityCERTIFICATE RELEASED
Applied Date2024-03-06
FDD Registration No11 I 3991/13
FDD Registration Date2024-06-22
Expiry Date2027-06-21

Back to drug list